Histopathological and molecular features of late relapses in non‐seminomas

Study Type – Therapy (case series) Level of Evidence 4

[1]  J. Baniel,et al.  Late Relapse of Testis Cancer , 2013, Current Urology Reports.

[2]  Hierarchical Architectures,et al.  Towards an Understanding of , 2011 .

[3]  E. Steyerberg,et al.  Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Motzer,et al.  Clinical outcome and predictors of survival in late relapse of germ cell tumor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Brice.  Managing relapsed and refractory Hodgkin lymphoma , 2008, British journal of haematology.

[6]  S. Kitazawa,et al.  Further characterization of the first seminoma cell line TCam‐2 , 2008, Genes, chromosomes & cancer.

[7]  R. Motzer,et al.  Medical treatment of advanced testicular cancer. , 2008, JAMA.

[8]  D. Vanel,et al.  Chemotherapy in patients with teratoma with malignant transformation. , 2007, European urology.

[9]  S. Fosså,et al.  Late relapses of germ cell malignancies: incidence, management, and prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Fosså,et al.  Late recurrences of germ cell malignancies: a population-based experience over three decades , 2006, British Journal of Cancer.

[11]  Yun-Fai Chris Lau,et al.  Germ cell lineage differentiation in non‐seminomatous germ cell tumours , 2006, The Journal of pathology.

[12]  J. Bacik,et al.  Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  I. Wistuba,et al.  Mismatch repair gene expression and genetic instability in testicular germ cell tumor , 2004, Cancer biology & therapy.

[14]  A. Horwich,et al.  Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials , 2004, British Journal of Cancer.

[15]  P. Albers,et al.  Late relapse of testicular cancer , 2004, World Journal of Urology.

[16]  S. Shiesh,et al.  Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. , 2004, Clinical chemistry.

[17]  P. Kantoff,et al.  Chemotherapy for teratoma with malignant transformation. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Bokemeyer,et al.  Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  C. Bokemeyer,et al.  Molecular determinants of treatment response in human germ cell tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  C. Bokemeyer,et al.  Advances in Brief Microsatellite Instability of Germ Cell Tumors Is Associated with Resistance to Systemic Treatment 1 , 2002 .

[21]  L. Einhorn.  Curing metastatic testicular cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence , 2000 .

[23]  H. Michael,et al.  The pathology of late recurrence of testicular germ cell tumors. , 2000, The American journal of surgical pathology.

[24]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  L. Looijenga,et al.  Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas. , 1999, American journal of human genetics.

[26]  W. Molenaar,et al.  Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. , 1998, Cancer.

[27]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[28]  D. Dearnaley,et al.  Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Ong,et al.  A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer. , 1997, British journal of urology.